Beijing Fourth Intermediate People’s Court Issues Judgement Against Sinobioway Medicine and Mr. Aihua Pan Business Wire - 9/28/2020 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/23/2020 11:05:23 AM
Sinovac’s Coronavac™, SARS-CoV-2 Vaccine (Vero Cell), Inactivated, Announces Approval for Phase I/II Clinical Trial in Ad... Business Wire - 9/23/2020 8:30:00 AM
Sinovac Commences Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey Business Wire - 9/22/2020 8:00:00 AM
Sinovac Reports Preliminary Phase I/II Results of COVID-19 Vaccine in Elderly Volunteers Business Wire - 9/9/2020 12:48:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/28/2020 5:04:42 PM
Sinovac Reports Unaudited Second Quarter 2020 Financial Results Business Wire - 8/28/2020 4:15:00 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/26/2020 6:54:36 AM
Sinovac Signs Agreement with Bio Farma Indonesia for COVID-19 Vaccine Cooperation Business Wire - 8/25/2020 8:30:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 7/6/2020 9:15:10 AM
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial Business Wire - 7/6/2020 9:00:00 AM
Recent SVA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2025 01:48:28 PM
- SINOVAC Issues Statement Regarding Privy Council Judgment • Business Wire • 01/16/2025 01:01:00 PM
- シノバック、手足口病(HFMD)に対する2価ワクチンの第III相臨床試験を開始 • Business Wire • 12/17/2024 01:06:00 PM
- SINOVAC hat eine klinische Phase-III-Studie zu einem bivalenten Impfstoff gegen Hand-Fuß-Mund-Krankheit (HFMD) initiiert • Business Wire • 12/17/2024 01:04:00 PM
- SINOVAC a lancé un essai clinique de Phase III sur un vaccin bivalent contre la maladie mains-pieds-bouche (MMPB) • Business Wire • 12/17/2024 01:02:00 PM
- SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD) • Business Wire • 12/16/2024 10:04:00 AM
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 09/12/2024 08:03:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2024 08:15:10 PM
- SINOVAC Reports Unaudited First Half of 2024 Financial Results • Business Wire • 08/16/2024 12:54:00 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 06/17/2024 08:02:44 PM
- SINOVAC Reports Unaudited Second Half of 2023 Financial Results and Files 2023 Annual Report on Form 20-F • Business Wire • 04/29/2024 09:53:00 PM
- Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend] • Edgar (US Regulatory) • 02/21/2024 11:09:13 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/21/2024 11:02:10 AM
- Sinovac Amends Shareholder Rights Plan • Business Wire • 02/21/2024 07:56:00 AM
- Form SC TO-T/A - Tender offer statement by Third Party: [Amend] • Edgar (US Regulatory) • 02/02/2024 04:19:55 PM
Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing • BLO • Jan 24, 2025 8:49 AM
UC Asset Announces Plan of Secondary Public Offering via Reg A • UCASU • Jan 23, 2025 9:30 AM
Luke Plants Featured in U.S. Department of the Interior Report to Congress on Strategic Review of National Orphan Well Program • ZEFIF • Jan 21, 2025 10:51 AM
North Bay Resources Acquires 70% Interest in the Bishop Gold Mill, Inyo County, California • NBRI • Jan 21, 2025 9:26 AM
HealthLynked Unveils Release of ARi: A Revolutionary AI-Powered Healthcare Assistant • HLYK • Jan 21, 2025 8:00 AM
Good Gaming Inc. Announces ViaOne Services' Intent to Purchase Up to 10% of Its Common Shares in the Open Market • GMER • Jan 16, 2025 8:30 AM